| Ambetter Health Texas Superior Marketplace Clinical | Mobocertinib | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Mogamulizumab-kpkc | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Motixafortide | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Nadofaragene Firadenovec-vncg | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Naloxegol | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Naproxen Oral Suspension | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Natalizumab, Natalizumab-sztn | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Necitumumab | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Neomycin/Fluocinolone Cream | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Neratinib | 2025-11-01 |